Login / Signup

Role of implicit bias in pediatric cancer clinical trials and enrollment recommendations among pediatric oncology providers.

Dylan E GraetzArshia MadniJeffrey GossettGuolian KangJanice A SabinVictor M SantanaCarolyn L Russo
Published in: Cancer (2020)
The authors noted a paucity of prior exposure to implicit bias self-assessments and training. Although these providers demonstrated preferences for high SES and European American race, this did not appear to affect recommendations for clinical trial enrollment as assessed by vignettes.
Keyphrases
  • clinical trial
  • health insurance
  • clinical practice
  • phase ii
  • papillary thyroid
  • childhood cancer
  • open label
  • palliative care
  • double blind
  • phase iii
  • squamous cell
  • affordable care act
  • young adults
  • healthcare